Credit Suisse Ag Bio Techne Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Bio Techne Corp stock. As of the latest transaction made, Credit Suisse Ag holds 257,045 shares of TECH stock, worth $18.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

257,045

Previous 259,201 0.83%

Holding current value

$18.3 Million

Previous $20 Million 9.53%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$65.98 - $77.09 $142,252 - $166,206	-2,156 Reduced 0.83%	257,045 $18.1 Million
Q4 2023 Feb 08, 2024	BUY	$52.83 - $78.22 $368,330 - $545,349	6,972 Added 2.76%	259,201 $20 Million
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $382,230 - $506,206	-5,661 Reduced 2.2%	252,229 $17.2 Million
Q2 2023 Aug 11, 2023	SELL	$73.76 - $85.98 $1.02 Million - $1.19 Million	-13,784 Reduced 5.07%	257,890 $21.1 Million
Q1 2023 May 10, 2023	BUY	$71.62 - $86.62 $656,039 - $793,439	9,160 Added 3.49%	271,674 $20.2 Million

Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $16.3 Million - $71 Million	201,658 Added 331.37%	262,514 $21.8 Million
Q3 2022 Nov 10, 2022	BUY	$282.54 - $391.85 $179,695 - $249,216	636 Added 1.06%	60,856 $17.3 Million
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $680,188 - $947,862	-2,108 Reduced 3.38%	60,220 $20.9 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $1.7 Million - $2.35 Million	4,812 Added 8.37%	62,328 $27 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $238,566 - $274,606	-523 Reduced 0.9%	57,516 $29.8 Million
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $67,620 - $81,909	-152 Reduced 0.26%	58,039 $28.1 Million
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $4.84 Million - $5.63 Million	12,495 Added 27.34%	58,191 $26.2 Million
Q1 2021 May 14, 2021	SELL	$314.62 - $411.0 $1.21 Million - $1.58 Million	-3,833 Reduced 7.74%	45,696 $17.5 Million
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $3.5 Million - $4.57 Million	14,194 Added 40.17%	49,529 $15.7 Million
Q3 2020 Nov 13, 2020	SELL	$232.22 - $282.96 $6.27 Million - $7.64 Million	-26,990 Reduced 43.31%	35,335 $8.75 Million
Q2 2020 Aug 12, 2020	BUY	$185.43 - $279.56 $917,322 - $1.38 Million	4,947 Added 8.62%	62,325 $16.5 Million
Q1 2020 May 13, 2020	BUY	$161.17 - $221.51 $2.74 Million - $3.76 Million	16,976 Added 42.02%	57,378 $10.9 Million
Q4 2019 Feb 12, 2020	BUY	$189.68 - $222.09 $2.81 Million - $3.3 Million	14,839 Added 58.05%	40,402 $8.87 Million
Q3 2019 Nov 12, 2019	SELL	$183.56 - $216.72 $1.45 Million - $1.72 Million	-7,918 Reduced 23.65%	25,563 $5 Million
Q2 2019 Aug 14, 2019	SELL	$188.72 - $215.43 $199,665 - $227,924	-1,058 Reduced 3.06%	33,481 $6.98 Million
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $418,204 - $615,952	3,073 Added 9.77%	34,539 $6.86 Million
Q4 2018 Feb 13, 2019	SELL	$132.75 - $203.8 $609,853 - $936,257	-4,594 Reduced 12.74%	31,466 $4.55 Million
Q3 2018 Nov 13, 2018	SELL	$147.44 - $204.11 $60,597 - $83,889	-411 Reduced 1.13%	36,060 $7.36 Million
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $766,231 - $875,587	-5,288 Reduced 12.66%	36,471 $5.4 Million
Q1 2018 May 15, 2018	SELL	$131.46 - $151.04 $170,898 - $196,352	-1,300 Reduced 3.02%	41,759 $6.31 Million
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $206,110 - $229,209	-1,701 Reduced 3.8%	43,059 $5.58 Million
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $742,310 - $808,902	6,535 Added 17.1%	44,760 $5.41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	38,225	38,225 $4.49 Million

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.79B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account